MNKD


Tuesday Morning’s Market Insights: MannKind Corporation (MKND), Skyworks Solutions Inc (SWKS), Canadian Solar Inc. (CSIQ), Organovo Holdings Inc (ONVO)

MannKind Corporation (NASDAQ:MNKD) is down almost 8% in early morning trading following disappointing Q3 earnings released yesterday after market-close. Specifically, the earnings highlighted …

Wall Street’s Week Ahead: MannKind Corporation (MNKD), Intercept Pharmaceuticals Inc (ICPT), Galena Biopharma Inc (GALE), Juno Therapeutics Inc (JUNO)

Several pharmaceutical giants will be releasing earnings reports this week. Here’s what to watch for in reports from MannKind Corporation (NASDAQ:MNKD), Intercept Pharmaceuticals …

Wednesday Morning’s Market Insights: MannKind Corporation (MNKD), Tesla Motors Inc (TSLA), Groupon Inc (GPRN), Stratasys, Ltd. (SSYS)

MannKind Corporation (NASDAQ:MNKD) fell 6.5% in pre-market trading down to $3.

Monday Morning Market Insights: MannKind Corporation (MNKD), Seadrill Ltd (SDRL), Chipotle Mexican Grill, Inc. (CMG), ACADIA Pharmaceuticals Inc. (ACAD)

MannKind Corporation (NASDAQ:MNKD) fell 6.65% in pre-market trading down to $3.

Wednesday’s Top Upgrades And Downgrades: Goldman Sachs, MannKind Corp, Tetraphase Pharmaceuticals, Pepco, Yingli, Walgreens Boots Alliance, E*TRADE, Plains GP Holdings

There has been a lot of action on Wall Street today as analysts have weighed in on their favorite stocks. Below are the …

MannKind Corporation ׁ(MNKD) Stock Falls on Analyst Downgrade

In a research report released today, Piper Jaffray analyst Joshua Schimmer downgraded shares of MannKind Corporation (NASDAQ:MNKD) from Perform to Underperform rating, while also slashing the …

Monday Morning Insights: Alibaba Group Holding Ltd (BABA), MannKind Corporation (MNKD), Seadrill Ltd (SDRL)

Alibaba Group Holding Ltd (NYSE:BABA) fell 9.21% to $61.

Biotech Beat: Synergy Pharmaceuticals Inc (SGYP), MannKind Corporation (MNKD), Ibio Inc (IBIO), Novavax, Inc. (NVAX)

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) is going through rough times in the market at the moment after missing expectations with regard to their most …

MannKind Corporation Beats Earnings Expectations, But Analysts Remain Skeptical

Biopharmaceutical company MannKind Corporation (NASDAQ:MNKD) impressed investors after posting second-quarter earnings yesterday before market open, sending shares up as much as 12% MannKind narrowly beat the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts